Compounds > ciprofloxacin

ciprofloxacin and pipemidic acid

ciprofloxacin has been researched along with pipemidic acid in 45 studies

Research

Studies (45)

TimeframeStudies, this research(%)All Research%
pre-199024 (53.33)18.7374
1990's5 (11.11)18.2507
2000's6 (13.33)29.6817
2010's9 (20.00)24.3611
2020's1 (2.22)2.80

Authors

AuthorsStudies
Domagala, JM; Hanna, LD; Heifetz, CL; Hutt, MP; Mich, TF; Sanchez, JP; Solomon, M1
Cha, R; Diwadkar, VU; Grucz, RG; Kaatz, GW; Kerns, RJ; Rybak, MJ; Vaka, F; Ward, TD1
Antón-Fos, GM; Duart, MJ; Mut-Ronda, S; Salabert-Salvador, MT1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Alamry, KA; Birs, AS; Gonzalez, CF; Ibrahim, MA; Katritzky, AR; Panda, SS; Serrano, JC1
Al-Mahmoudy, AMM; Alamry, KA; Asiri, AM; Faidallah, HM; Girgis, AS; Honkanadavar, HH; Ibrahim, TS; Kalmouch, A; Khan, KA; Panda, SS; Samir, A; Thomas, SJ; Tiwari, AD1
Chu, XM; Gong, KK; Liang, LL; Liu, W; Sun, KL; Wang, C; Zhao, CY1
Ciura, K; Fallarero, A; Fedorowicz, J; Gilbert-Girard, S; Konopacka, A; Lejnowski, D; Morawska, M; Sączewski, J; Savijoki, K; Skok, Ž; Tomašič, T; Waleron, K1
Gao, F; Huang, G; Xiao, J1
Barnett, G; Carbó, M; de la Torre, R; Segura, J1
Nishino, T; Obana, Y1
Harder, S; Papenburg, A; Staib, AH; Stille, W1
Beer, C; Harder, S; Papenburg, A; Shah, PM; Staib, AH; Stille, W1
Lerk, CF; Stoutenbeek, CP; van Saene, HK; van Saene, JJ1
Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL2
Cremer, AW; Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL; Robbins, MJ; Wall, RA; Williams, AH1
Barba, D; Esposito, S; Galante, D; Pennucci, C2
Grimm, H2
Imagawa, Y; Ito, K; Masuda, G; Matsubara, Y; Negishi, M; Sagara, H; Seo, T; Tagawa, K; Takizawa, Y; Tomizawa, I1
Cancet, B; Clave, D; Didier, J; Henry-Ferry, S; Marty, N1
Niki, Y; Soejima, R; Tasaka, Y; Umeki, S; Watanabe, M1
Traub, WH2
Allocati, N; Cellini, L; Di Girolamo, A; Piccolomini, R; Scazzocchio, F; Selan, L1
Guenounou, M; Kodari, E; Momrikof, V; Ronco, E; Vacheron, F1
Kawane, H; Niki, Y; Soejima, R; Sumi, M; Umeki, S1
Smith, JT1
Steele, LC; Wallace, RJ1
Muytjens, HL; van der Ros-van de Repe, J; van Veldhuizen, G1
Heessen, FW; Muytjens, HL1
Castaño Rodríguez, A; Fernández Fernández, A; Fernández Santos, F; Gastañares Hernando, MJ; Gil Fabra, J; Lantero Benedito, M; Martínez Castellanos, F; Otero Mauricio, G; Undabeitia Santisteban, E1
Cilla, G; García-Arenzana, JM; Jimenez, D; Pérez-Trallero, E; Urbieta, M1
Dávila, I; De La Hoz, B; Diez, ML; Fraj, J; Lazaro, M; Quirce, S1
Branstetter, DG; Hampton, LA; Linseman, DA1
Cha, R; Diwadkar, VU; Grucz, RG; Kaatz, GW; Kerns, RJ; Rybak, MJ; Vaka, F1
Duan, GC; Xi, YL; Zhu, JY1
Depta, JP; Pichler, WJ; Schmid, DA1
Itoh, T; Mitsumori, K; Moto, M; Sakai, H; Takahashi, M1
Borja Segade, J; Castro Jiménez, A; Feo Brito, FJ; Galindo Bonilla, PA; García Rodríguez, R; Gómez Torrijos, E; Lara de la Rosa, P1
Abrams, MJ; Mjos, KD; Orvig, C; Polishchuk, E1
Buddana, SK; Dileep, K; Jain, N; Murty, MSR; Polepalli, S; Prakasham, RS1
Haider Naqvi, SZ; Malik, A; Muddassir, M; Mumtaz, K; Munir, S; Raza, A; Shoaib Ahmed, S; Waqas, K1

Reviews

2 review(s) available for ciprofloxacin and pipemidic acid

ArticleYear
Quinoline and quinolone dimers and their biological activities: An overview.
    European journal of medicinal chemistry, 2019, Jan-01, Volume: 161

    Topics: Anti-Bacterial Agents; Antimalarials; Antineoplastic Agents; Bacteria; Dimerization; Humans; Neoplasms; Quinolines; Quinolones

2019
Current scenario of tetrazole hybrids for antibacterial activity.
    European journal of medicinal chemistry, 2019, Dec-15, Volume: 184

    Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles

2019

Trials

2 trial(s) available for ciprofloxacin and pipemidic acid

ArticleYear
4-quinolones inhibit biotransformation of caffeine.
    European journal of clinical pharmacology, 1988, Volume: 35, Issue:6

    Topics: Adult; Biotransformation; Caffeine; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Interactions; Enoxacin; Humans; Male; Molecular Structure; Norfloxacin; Ofloxacin; Pipemidic Acid; Quinolones; Random Allocation; Theophylline

1988
[Comparison of clinical efficacy of ciprofloxacin (CPFX, BAY o 9867) and pipemidic acid (PPA) in the treatment of infectious enteritis by a double-blind method. The Japan Research Committee of Ciprofloxacin, Research Group for Infectious Enteritis].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1988, Volume: 62, Issue:4

    Topics: Adolescent; Adult; Aged; Ciprofloxacin; Clinical Trials as Topic; Double-Blind Method; Dysentery, Bacillary; Enteritis; Humans; Middle Aged; Nicotinic Acids; Pipemidic Acid

1988

Other Studies

41 other study(ies) available for ciprofloxacin and pipemidic acid

ArticleYear
New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
    Journal of medicinal chemistry, 1986, Volume: 29, Issue:3

    Topics: Anti-Bacterial Agents; Bacteria; DNA, Bacterial; DNA, Superhelical; Escherichia coli; Microbial Sensitivity Tests; Naphthyridines; Plasmids; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors

1986
Piperazinyl-linked fluoroquinolone dimers possessing potent antibacterial activity against drug-resistant strains of Staphylococcus aureus.
    Bioorganic & medicinal chemistry letters, 2003, May-19, Volume: 13, Issue:10

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Cross-Linking Reagents; Dimerization; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Piperazines; Staphylococcus aureus; Structure-Activity Relationship

2003
Search compounds with antimicrobial activity by applying molecular topology to selected quinolones.
    Bioorganic & medicinal chemistry letters, 2003, Aug-18, Volume: 13, Issue:16

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Discriminant Analysis; Drug Design; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship; Quinolones

2003
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Synthesis and antibacterial evaluation of amino acid-antibiotic conjugates.
    Bioorganic & medicinal chemistry letters, 2014, Apr-01, Volume: 24, Issue:7

    Topics: Amino Acids; Anti-Bacterial Agents; Bacillus subtilis; Dose-Response Relationship, Drug; Escherichia coli; Metronidazole; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas aeruginosa; Quinolones; Staphylococcus aureus; Structure-Activity Relationship; Sulfadiazine

2014
Synthesis, antibacterial properties and 2D-QSAR studies of quinolone-triazole conjugates.
    European journal of medicinal chemistry, 2018, Jan-01, Volume: 143

    Topics: Anti-Bacterial Agents; Bacteria; Chemistry Techniques, Synthetic; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship; Quinolones; Triazoles

2018
Synthesis and biological evaluation of hybrid quinolone-based quaternary ammonium antibacterial agents.
    European journal of medicinal chemistry, 2019, Oct-01, Volume: 179

    Topics: Anti-Bacterial Agents; DNA Gyrase; DNA Topoisomerase IV; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Quaternary Ammonium Compounds; Quinolones; Structure-Activity Relationship

2019
Pharmacokinetic determination of relative potency of quinolone inhibition of caffeine disposition.
    European journal of clinical pharmacology, 1990, Volume: 39, Issue:1

    Topics: Caffeine; Ciprofloxacin; Drug Interactions; Enoxacin; Humans; Male; Models, Biological; Norfloxacin; Ofloxacin; Pipemidic Acid; Quinolones

1990
In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice.
    Drugs under experimental and clinical research, 1989, Volume: 15, Issue:2

    Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Escherichia coli Infections; Female; Mice; Microbial Sensitivity Tests; Neutropenia; Norfloxacin; Ofloxacin; Pipemidic Acid; Time Factors; Urinary Tract Infections; Uterus

1989
[Gyrase inhibitors modify metabolising processes in the liver].
    Deutsche medizinische Wochenschrift (1946), 1987, Oct-30, Volume: 112, Issue:44

    Topics: Caffeine; Ciprofloxacin; DNA Topoisomerases, Type II; Enoxacin; Humans; Liver; Male; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Topoisomerase II Inhibitors

1987
Influence of faeces on the activity of antimicrobial agents used for decontamination of the alimentary canal.
    Scandinavian journal of infectious diseases, 1985, Volume: 17, Issue:3

    Topics: Anti-Bacterial Agents; Aztreonam; Ciprofloxacin; Colistin; Digestive System; Dose-Response Relationship, Drug; Feces; Humans; Nalidixic Acid; Neomycin; Norfloxacin; Pipemidic Acid; Quinolines; Tobramycin

1985
The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
    Drugs under experimental and clinical research, 1985, Volume: 11, Issue:4

    Topics: 4-Quinolones; Aeromonas; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter fetus; Cinoxacin; Ciprofloxacin; Diarrhea; Enoxacin; Fluoroquinolones; Humans; In Vitro Techniques; Intestines; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Salmonella; Shigella; Vibrio cholerae; Vibrio parahaemolyticus; Yersinia enterocolitica

1985
The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
    Drugs under experimental and clinical research, 1985, Volume: 11, Issue:4

    Topics: 4-Quinolones; Anti-Infective Agents; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Streptococcus pneumoniae

1985
Comparative in vitro studies with 4-quinolone antimicrobials.
    Drugs under experimental and clinical research, 1985, Volume: 11, Issue:5

    Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones

1985
Comparative in vitro activity of ciprofloxacin and five other quinoline derivatives against gram-negative isolates.
    Drugs under experimental and clinical research, 1985, Volume: 11, Issue:5

    Topics: Bacteriuria; Cinoxacin; Ciprofloxacin; Gram-Negative Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Pipemidic Acid; Quinolines

1985
[In vitro activity of seven gyrase inhibitors of a group of heterocyclic carbonic acids against nonfermenting gram negative rods (nonfermenters)].
    Arzneimittel-Forschung, 1985, Volume: 35, Issue:3

    Topics: Anti-Bacterial Agents; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Gram-Negative Aerobic Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Pseudomonas aeruginosa; Quinolines; Topoisomerase II Inhibitors

1985
[In vitro activity of new quinolones against nonfermenters and references to sensitivity tests].
    Infection, 1986, Volume: 14 Suppl 3

    Topics: Acinetobacter; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Gram-Negative Bacteria; Immunodiffusion; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Pseudomonas

1986
[Corynebacterium group D2. Clinical study, biochemical identification and antibiotic sensitivity].
    Pathologie-biologie, 1988, Volume: 36, Issue:5

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Corynebacterium; Corynebacterium Infections; Drug Resistance, Microbial; Enoxacin; Female; Humans; Male; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Peptides, Cyclic; Pipemidic Acid; Rifampin; Tetracycline; Tetracycline Resistance; Urinary Tract Infections; Vancomycin; Virginiamycin

1988
Therapeutic effect of fleroxacin against experimental pneumonia in mice.
    The Journal of antimicrobial chemotherapy, 1988, Volume: 22 Suppl D

    Topics: Animals; Anti-Infective Agents; Cefaclor; Ciprofloxacin; Fleroxacin; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Pipemidic Acid

1988
Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin.
    Chemotherapy, 1985, Volume: 31, Issue:1

    Topics: Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Pipemidic Acid; Quinolines; Serratia marcescens

1985
Cross resistance of quinolone derivatives in gram-negative bacteria.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1985, Volume: 4, Issue:2

    Topics: Ciprofloxacin; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Mutation; Nalidixic Acid; Nicotinic Acids; Oxolinic Acid; Pipemidic Acid; Quinolines

1985
In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1988, Volume: 7, Issue:5

    Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Pefloxacin; Pipemidic Acid; Proteus; Providencia; Urinary Tract Infections

1988
[Modulation by quinolones of the in vitro proliferative response of splenic cells of the mouse and IL 1 production].
    Pathologie-biologie, 1987, Volume: 35, Issue:5 Pt 2

    Topics: Animals; Anti-Infective Agents; Cell Division; Cells, Cultured; Ciprofloxacin; Interleukin-1; Macrophages; Male; Mice; Mice, Inbred DBA; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pipemidic Acid; Spleen

1987
New synthetic quinolone antibacterial agents and serum concentration of theophylline.
    Chest, 1987, Volume: 92, Issue:4

    Topics: Adult; Anti-Infective Agents; Chemical Phenomena; Chemistry; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pipemidic Acid; Theophylline

1987
Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Scandinavian journal of infectious diseases. Supplementum, 1986, Volume: 49

    Topics: 4-Quinolones; Anti-Bacterial Agents; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Escherichia coli; Fluoroquinolones; Mutation; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pipemidic Acid; Quinolines; Quinolizines; Quinolones

1986
Ability of ciprofloxacin but not pipemidic acid to differentiate all three biovariants of Mycobacterium fortuitum from Mycobacterium chelonae.
    Journal of clinical microbiology, 1987, Volume: 25, Issue:2

    Topics: Ciprofloxacin; Drug Resistance, Microbial; Humans; Mycobacterium; Nicotinic Acids; Nontuberculous Mycobacteria; Pipemidic Acid

1987
Intraphagocytic bactericidal activity of bacterial DNA gyrase inhibitors against Serratia marcescens.
    Chemotherapy, 1984, Volume: 30, Issue:6

    Topics: Blood Bactericidal Activity; Ciprofloxacin; Culture Media; Enoxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Phagocytosis; Pipemidic Acid; Quinolines; Serratia marcescens; Topoisomerase II Inhibitors

1984
Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.
    Antimicrobial agents and chemotherapy, 1983, Volume: 24, Issue:2

    Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Nicotinic Acids; Norfloxacin; Pipemidic Acid; Quinolines

1983
In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatis.
    Antimicrobial agents and chemotherapy, 1984, Volume: 25, Issue:1

    Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Cinoxacin; Ciprofloxacin; Humans; Nalidixic Acid; Norfloxacin; Pipemidic Acid; Quinolines

1984
[Quinolone-resistant Escherichia coli in the health area of a 650-bed hospital].
    Actas urologicas espanolas, 1994, Volume: 18, Issue:6

    Topics: Catchment Area, Health; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Hospital Bed Capacity, 500 and over; Humans; Microbial Sensitivity Tests; Norfloxacin; Pipemidic Acid; Retrospective Studies; Spain; Urinary Tract Infections

1994
Ten-year survey of quinolone resistance in Escherichia coli causing urinary tract infections.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1993, Volume: 12, Issue:5

    Topics: Anti-Infective Agents; Ciprofloxacin; Data Collection; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Humans; Longitudinal Studies; Norfloxacin; Pipemidic Acid; Urinary Tract Infections

1993
Cross-reactivity between quinolones. Report of three cases.
    Allergy, 1993, Volume: 48, Issue:5

    Topics: Adult; Anaphylaxis; Anti-Infective Agents; Ciprofloxacin; Drug Hypersensitivity; Female; Humans; Middle Aged; Nalidixic Acid; Pipemidic Acid

1993
Quinolone-induced arthropathy in the neonatal mouse. Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin.
    Fundamental and applied toxicology : official journal of the Society of Toxicology, 1995, Volume: 28, Issue:1

    Topics: Animals; Animals, Newborn; Anti-Infective Agents; Body Weight; Cartilage, Articular; Ciprofloxacin; Female; Foot; Joint Diseases; Mice; Pipemidic Acid; Pregnancy; Quinolones

1995
Structural features of piperazinyl-linked ciprofloxacin dimers required for activity against drug-resistant strains of Staphylococcus aureus.
    Bioorganic & medicinal chemistry letters, 2003, Jul-07, Volume: 13, Issue:13

    Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Mutation; Pipemidic Acid; Piperazines; Staphylococcus aureus; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors

2003
[Study on the molecular mechanism of quinolone resistance in Shigellae spp].
    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 2004, Volume: 25, Issue:3

    Topics: Anti-Infective Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Pipemidic Acid; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Quinolones; Shigella

2004
T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2006, Volume: 36, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antigen-Presenting Cells; Aza Compounds; Cell Proliferation; Cells, Cultured; Ciprofloxacin; Clone Cells; Cross Reactions; Drug Hypersensitivity; Enoxacin; Female; Fluoroquinolones; Humans; Hypersensitivity, Delayed; Middle Aged; Moxifloxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Patch Tests; Pipemidic Acid; Quinolines; Quinolones; T-Lymphocytes

2006
Liver initiation activity of norfloxacin but not nalidixic acid, pipemidic acid, and ciprofloxacin on in vivo short-term liver initiation assay in rats.
    Toxicology, 2006, May-15, Volume: 222, Issue:3

    Topics: 2-Acetylaminofluorene; Animals; Anti-Infective Agents; Carbon Tetrachloride; Carcinogens; Ciprofloxacin; Glutathione Transferase; Liver; Male; Nalidixic Acid; Norfloxacin; Pipemidic Acid; Rats; Rats, Inbred F344

2006
Chronic desensitization to quinolones in fixed drug eruption.
    Journal of investigational allergology & clinical immunology, 2011, Volume: 21, Issue:1

    Topics: Adult; Ciprofloxacin; Cystic Fibrosis; Desensitization, Immunologic; Drug Eruptions; Erythema; Female; Humans; Pipemidic Acid; Quinolones

2011
Synthesis, characterization, and evaluation of the antimicrobial potential of copper(II) coordination complexes with quinolone and p-xylenyl-linked quinolone ligands.
    Journal of inorganic biochemistry, 2016, Volume: 162

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Coordination Complexes; Copper; Gram-Negative Bacteria; Gram-Positive Bacteria; Ligands; Microbial Viability; Pipemidic Acid

2016
Synthesis of novel tetrazole containing hybrid ciprofloxacin and pipemidic acid analogues and preliminary biological evaluation of their antibacterial and antiproliferative activity.
    Molecular diversity, 2018, Volume: 22, Issue:1

    Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacteria; Cell Line, Tumor; Cell Proliferation; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Molecular Structure; Pipemidic Acid; Structure-Activity Relationship; Tetrazoles

2018
Antibiogram and molecular characterization of multi-drug resistant microorganisms isolated from urinary tract infections.
    Pakistan journal of pharmaceutical sciences, 2021, Volume: 34, Issue:3(Suppleme

    Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nitrofurantoin; Oxacillin; Pakistan; Pipemidic Acid; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections

2021